# MR-ADAPTOR (NCT03224000)

> Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer

No report yet. It can be ordered.

- Drugs tested: none (the trial tests a strategy, not a drug)
- Indication: HPV+ oropharyngeal squamous cell carcinoma

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03224000
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: M.D. Anderson Cancer Center
- Conditions: Malignant Neoplasms of Lip Oral Cavity and Pharynx; Oropharyngeal Cancer
- Interventions: Modified Barium Swallow (MBS); Swallowing Questionnaire; Symptom Questionnaire; Video-Strobe Procedure; MRI Guided Intensity Modulated Radiotherapy (IMRT) Planning; Standard-of-Care Intensity Modulated Radiotherapy (IMRT) Planning; Intensity Modulated Radiotherapy (IMRT)
- Enrollment: 90
- Primary outcome: Locoregional Control
- Primary outcome: Composite Dysphagia Outcome Determined by PEG Tube Dependence at Last Follow-Up
- Primary outcome: Composite Dysphagia Outcome Determined by Trace or Frank Aspiration Seen on Modified Barium Swallow Study
- Primary outcome: Composite Dysphagia Outcome Determined by Diagnosis of Aspiration Pneumonia
- Primary outcome: Composite Dysphagia Outcome Determined by Presence of Pharyngoesophageal Structure on Modified Barium Swallow Study
- Primary outcome: Composite Dysphagia Outcome Determined by Presence of Pharyngoesophageal Structure on Endoscopy with Subsequent Need for Dilation

## Indexed commentary on MR-ADAPTOR so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 3 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=mr-adaptor-nct03224000